Cargando…
Non-Invasive Prenatal Testing of Trisomy 18 by an Epigenetic Marker in First Trimester Maternal Plasma
BACKGROUND: Quantification of cell-free fetal DNA by methylation-based DNA discrimination has been used in non-invasive prenatal testing of fetal chromosomal aneuploidy. The maspin (Serpin peptidase inhibitor, clade B (ovalbumin), member 5; SERPINB5) gene, located on chromosome 18q21.33, is hypometh...
Autores principales: | Lee, Da Eun, Kim, Shin Young, Lim, Ji Hyae, Park, So Yeon, Ryu, Hyun Mee |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3815335/ https://www.ncbi.nlm.nih.gov/pubmed/24223769 http://dx.doi.org/10.1371/journal.pone.0078136 |
Ejemplares similares
-
Non-Invasive Epigenetic Detection of Fetal Trisomy 21 in First Trimester Maternal Plasma
por: Lim, Ji Hyae, et al.
Publicado: (2011) -
Disease specific characteristics of fetal epigenetic markers for non-invasive prenatal testing of trisomy 21
por: Lim, Ji Hyae, et al.
Publicado: (2014) -
Non-invasive prenatal diagnosis of fetal trisomy 21 using cell-free fetal DNA in maternal blood
por: Lim, Ji Hyae, et al.
Publicado: (2013) -
Quantification and Application of Potential Epigenetic Markers in Maternal Plasma of Pregnancies with Hypertensive Disorders
por: Kim, Hyun Jin, et al.
Publicado: (2015) -
Noninvasive Prenatal Diagnosis of Fetal Trisomy 18 and Trisomy 13 by Maternal Plasma DNA Sequencing
por: Chen, Eric Z., et al.
Publicado: (2011)